No abstract available
MeSH terms
-
Adrenergic beta-Antagonists / administration & dosage*
-
Adult
-
Defibrillators, Implantable*
-
ERG1 Potassium Channel / genetics*
-
Electrocardiography / methods
-
Female
-
Gestational Age
-
Humans
-
Infant, Newborn
-
Infant, Newborn, Diseases / diagnosis
-
Infant, Newborn, Diseases / drug therapy
-
Infant, Newborn, Diseases / genetics
-
Long QT Syndrome* / diagnosis
-
Long QT Syndrome* / genetics
-
Long QT Syndrome* / physiopathology
-
Long QT Syndrome* / therapy
-
Mexiletine / administration & dosage*
-
Mutation
-
Pregnancy
-
Pregnancy Complications, Cardiovascular* / diagnosis
-
Pregnancy Complications, Cardiovascular* / physiopathology
-
Pregnancy Complications, Cardiovascular* / surgery
-
Pregnancy Outcome
-
Pregnancy, Unplanned
-
Treatment Outcome
-
Voltage-Gated Sodium Channel Blockers / administration & dosage
Substances
-
Adrenergic beta-Antagonists
-
ERG1 Potassium Channel
-
KCNH2 protein, human
-
Voltage-Gated Sodium Channel Blockers
-
Mexiletine